ArticleThe American journal of case reports2026
Delayed Myoclonus and Bilateral Globus Pallidus Lesions Following Organophosphate Poisoning: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Organophosphate-induced delayed neuropathy is a well-known peripheral nervous system manifestation of organophosphate poisoning. However, organophosphate poisoning can also present with delayed central nervous system complications, such as myoclonus. Although peripheral neuropathy has been extensively described in the literature, central nervous system involvement remains relatively underrecognized. Neuroimaging findings in such cases play a crucial role in revealing the underlying toxic injury and structures involved. CASE REPORT A 49-year-old man with organophosphate poisoning recovered from the acute cholinergic phase and intermediate syndrome but developed myoclonus 3 to 4 weeks after organophosphate ingestion. Magnetic resonance imaging (MRI) of the brain showed T2-weighted and FLAIR hyperintensities in the bilateral globus pallidus, suggestive of a toxic insult to the subcortex. The patient received steroids, intravenous immunoglobulin, and symptomatic treatment for myoclonus, with no success. CONCLUSIONS This case highlights a unique complication of myoclonus with brain MRI changes in the setting of organophosphate exposure. The patient recovered from acute cholinergic crisis and intermediate syndrome but developed new-onset neurological deficits during the delayed phase. Such complications can significantly contribute to long-term morbidity and impair quality of life. This report highlights a clinically relevant but underrecognized delayed presentation of organophosphate poisoning. Given the limited number of such reports, this case adds incremental knowledge and helps clinicians recognize similar presentations in practice. Although a causal relationship cannot be definitively established, the temporal association raises the possibility of organophosphate exposure and globus pallidus signal changes in the presence of myoclonus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.